Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06781034

Descriptive Study on MRI Contrast of Acute Cerebral Hemorrhage in Different Microangiopathies

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
128 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cerebral haemorrhage represents a minority of acute vascular syndromes (less frequent than ischemic stroke, at around 20%), but with a therapeutic impasse, having no specific treatment. Arterial contrast ("spot sign") within the hematoma has been described in CT scans as a risk factor for further enlargement and poor prognosis. An equivalent marker has also been described in gadolinium-enhanced MRI. By studying the radiological appearance of gadolinium "spot signs" on MRI, which has better parenchymal resolution, the researchers propose to retrace the phenomenology of the acute phase of cerebral hemorrhage in order to better estimate the risk of radiological aggravation by subgroup, which could serve as a target population for future therapeutic trials.

Conditions

Interventions

TypeNameDescription
OTHERNone, pure observational studyNone, pure observational study

Timeline

Start date
2025-02-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-01-17
Last updated
2025-01-17

Source: ClinicalTrials.gov record NCT06781034. Inclusion in this directory is not an endorsement.